Data / Form D filings / BIOLIFE SOLUTIONS INC
BIOLIFE SOLUTIONS INC: Form D filing
BIOLIFE SOLUTIONS INC, a biotechnology company in Bothell, WA, filed a Form D with the SEC in 2023. The latest, on October 27, 2023, reports $10.4 million sold of a $10.4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3303 MONTE VILLA PARKWAY, Bothell, WA, 98021
- Phone
- (425) 402-1400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 834365
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2023 | New notice | $10,374,976 | $10,374,976 | 1 | Oct 19, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rachel Ellingson | Director | |
| Joydeep Goswami | Director | |
| Amy DuRoss | Director | |
| Karen Foster | Executive Officer | |
| Troy Wichterman | Executive Officer | |
| Michael Rice | Executive Officer, Director | |
| Sarah Aebersold | Executive Officer | |
| Joseph Schick | Director | |
| Aby Mathew | Executive Officer | |
| Todd Berard | Executive Officer | |
| Roderick De Greef | Executive Officer, Director | |
| Geraint Phillips | Executive Officer | |
| Tim Moore | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Oct 23, 2023 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BIOLIFE SOLUTIONS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.